American Century Companies’s Aurinia Pharmaceuticals AUPH Stock Holding History

American Century Companies's AUPH Position: Q1 2026 in Review

American Century Companies reduced its Aurinia Pharmaceuticals (AUPH) stake by 9.4% in Q1 2026, selling an estimated $551K and leaving 365,236 shares worth $5.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1746.

American Century Companies first reported a position in AUPH in Q1 2023 and has held it in 9 quarters since. The position peaked at $6.43M in Q4 2025. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

• American Century Companies held 365,236 shares of Aurinia Pharmaceuticals worth $5.41M as of Q1 2026.
• American Century Companies sold 37,689 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $551K.
• Aurinia Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #1746 holding.
• American Century Companies first reported a position in Aurinia Pharmaceuticals in Q1 2023 and has held it in 9 quarters since.
• American Century Companies's Aurinia Pharmaceuticals position peaked at $6.43M in Q4 2025.
• 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.